Abbott Laboratories (ABT) — 10-Q Filings

10-Q Filings (6)

• Abbott's Q3 Net Earnings Flat Amid Strong Device Sales, COVID Test Slump — Oct 29, 2025 Risk: medium
  Abbott Laboratories reported a slight decrease in net earnings for the three months ended September 30, 2025, at $1,644 million, compared to $1,646 million in t
• Abbott Posts Strong Q2 Growth, Net Sales Up 4.9% — Jul 30, 2025 Risk: low
  Abbott Laboratories reported robust financial performance for the second quarter ended June 30, 2025, with net sales reaching $10.465 billion, a significant inc
• Abbott Labs Files Q1 2025 10-Q — Apr 30, 2025 Risk: low
  Abbott Laboratories filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and position, including its fisc
• Abbott Labs Files Q3 2024 10-Q — Oct 31, 2024 Risk: low
  Abbott Laboratories filed its 10-Q for the period ending September 30, 2024. The filing details financial performance and operational updates for the third quar
• Abbott Labs Files Q2 2024 10-Q — Jul 31, 2024 Risk: low
  Abbott Laboratories filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter and first half of 2024, detailing financial perform
• Abbott Laboratories Files 10-Q for Period Ending March 31, 2024 — May 2, 2024 Risk: low
  ABBOTT LABORATORIES (ABT) filed a Quarterly Report (10-Q) with the SEC on May 2, 2024. Abbott Laboratories filed its 10-Q report for the quarterly period ended

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX